14544 Federal Register / Vol. 87, No. 50 / Tuesday, March 15, 2022 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: March 10, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05464 Filed 3–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Cancer Institute 

Board of Scientific Advisors. 

The meeting will be held as a virtual 

meeting and is open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations to 

view the meeting, should notify the 

Contact Person listed below in advance 

of the meeting. The meeting will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov/). 

Name of Committee: National Cancer 

Institute Board of Scientific Advisors. 

Date: March 28, 2022. 

Time: 1:00 p.m. to 5:30 p.m. 

Agenda: Director’s Report; RFA, RFP, and 

PAR Concept Reviews; and Scientific 

Presentations. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20850 (Virtual Meeting). 

Date: March 29, 2022. 

Time: 1:00 p.m. to 5:30 p.m. 

Agenda: RFA, RFP, and PAR Concept 

Reviews; and Scientific Presentations. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20852 (Virtual Meeting). 

Contact Person: Paulette S. Gray, Ph.D., 

Director, Division of Extramural Activities, 

National Cancer Institute—Shady Grove, 

National Institutes of Health, 9609 Medical 

Center, Drive, 7th Floor, Room 7W444, 

Bethesda, MD 20892, 240–276–6340, grayp@

mail.nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: BSA: 

http://deainfo.nci.nih.gov/advisory/bsa/ 

bsa.htm, where an agenda and any 

additional information for the meeting 

will be posted when available. 

This notice is being published less 

than 15 days prior to the meeting due 

to scheduling difficulties. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: March 10, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05467 Filed 3–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; NIH COVID–19 

Vaccination Status Form Extension 

AGENCY: National Institutes of Health, 

Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact: Dr. Jessica 

McCormick-Ell, Ph.D., SM (NRCM), 

CBSP, RBP, NIH/ORS/SR/DOHS, Bldg. 

13/3W80, Bethesda, MD, 20892–5760 or 

call non-toll-free number (301) 496– 

0590 or email your request, including 

your address to: jessica.mccormick-ell@

nih.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on November 22, 2021 (86 FR 

66319), and allowed 60 days for public 

comment. No public comments were 

received. The purpose of this notice is 

to allow an additional 30 days for public 

comment. The Office of Research 

Services, National Institutes of Health, 

may not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: NIH COVID–19 

Vaccination Status Form, REVISION, 

0925–0771, exp., 3/31/2022, Office of 

Research Services (ORS), National 

Institutes of Health (NIH). 

Need and Use of Information 

Collection: This revision request 

includes two new forms as NIH is 

implementing a building entry protocol 

where all people, Federal Government 

employees, contractors, patients, and 

visitors, will answer questions about 

COVID exposure every day. The NIH 

COVID–19 Vaccination Status Form will 

continue to ensure the safety of the 

Federal workplace consistent with 

Executive Order 14042, Ensuring 

Adequate COVID Safety Protocols for 

Federal Contractors, Executive Order 

14043, Requiring Coronavirus Disease 

2019 Vaccination for Federal 

Employees, the COVID–19 Workplace 

Safety: Agency Model Safety Principles 

established by the Safer Federal 

Workforce Task Force, and guidance 

from the Centers for Disease Control and 

Prevention (CDC) and the Occupational 

Safety and Health Administration 

(OSHA). The proposed information 

collection will continue to be used to 

ensure compliance with vaccination 

requirements in the authorities above, 

generate the list of persons required to 

be tested on a routine basis, and will 

provide important information 


khammond on DSKJM1Z7X2PROD with NOTICES